.png)
SAN DIEGO - Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced the successful conclusion of a four-part podcast series on human biological samples and biobanking. The four guests offered thoughtful insights and ideas from an academia, pharmaceutical and small business perspective. The episodes were hosted by Mendelspod, one of the life science industry’s leading podcasts.
“This is the second time we’ve covered human biospecimen quality and governance on this show, which tells me that people are interested and looking for answers,” said Theral Timpson, Host, Producer and Co-Founder of Mendelspod. “What Scientist.com is doing—offering a self-regulatory solution within the life sciences—is a practical first step toward filling an important gap.”
Guests in the series featured experts in biospecimen regulation, biobanking and compliance, including Carolyn Compton, PhD, Chief Medical Officer of the National Biomarker Development Alliance and ASU professor; Shannon McCall, PhD, Director of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University; Kirstin Goldring, PhD, Counselor at the European Society for Biopreservation and Biobanking and member of ISBER; and Matt McLoughlin, Vice President of Compliance at Scientist.com. Topics covered ranged from the sustainability of biobanks to a discussion of COMPLiTM—Scientist.com’s proprietary compliance framework for overseeing the acquisition of human biological samples for research.
“It was an honor to be included amongst a group of such distinguished and knowledgeable speakers on the topic of human biospecimen quality and biobanking,” commented Matt McLoughlin, VP of Compliance at Scientist.com. “Forums like these raise awareness regarding the sustainability of biobanks and help us create a more standardized set of rules governing human biospecimen acquisition.”
All podcasts are accessible free of charge at https://mendelspod.com/.
.webp)
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.